Taking drugs through your eyes could be a US$29 billion market by 2030
Implantable method allows drugs to be administered through depots kept in the eye
A next generation of implantable eye treatments could change the way we treat eye conditions.
And, according to a new report by Citi GPS, this experimental way to deliver eye care could turn into a US$29 billion market by 2030, up from US$16 billion in 2016.
With the implantable method, drugs can be delivered through depots kept in the eye.
"A new wave of technologies is leveraging the eye as a natural, self-contained drug delivery chamber," Citi biotech analyst Yigal Nochomovitz wrote in the report.
Eye diseases are becoming increasingly common, he noted, with about 34 million people being affected by either glaucoma, retinal diseases, or dry eye by 2050.
Here's how the implant works, as pictured on the right: